See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 26, 2006

Follicular Lymphoma Osteoarthritis Genital Herpes

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Follicular Lymphoma

You may be eligible for this clinical study of an investigational agent if you have follicular lymphoma and treatment has failed with rituximab in combination with chemotherapy, or with rituximab as a maintenance treatment.

The research site is in La Jolla, Calif.

More information

Please see



This six-month study will evaluate the safety and effectiveness of an investigational agent compared to an inactive placebo in adults with daily moderate-to-severe knee pain due to osteoarthritis. Additional criteria apply.

The research site is in Boise, Idaho.

More information

Please see


Genital Herpes

This study will evaluate an investigational medication to see if it reduces healing time for genital herpes outbreaks. To qualify, you must be at least 18, medically diagnosed with genital herpes, and be in good general health.

The research site is in Billings, Mont.

More information

Please see


Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.